Periscope Capital’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Periscope Capital’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$10.8K	–	506
2023 Q4	$10.8K	Hold	200,000	–	–	﹤0.01%	387
2023 Q3	$11.7K	Hold	200,000	–	–	﹤0.01%	516
2023 Q2	$11.5K	Hold	200,000	–	–	﹤0.01%	598
2023 Q1	$10K	Sell	200,000 -50,787	-20%	-$4.57K	﹤0.01%	723
2022 Q4	$30.5K	Sell	250,787 -16,498	-6%	-$2.06K	﹤0.01%	627
2022 Q3	$32K	Hold	267,285	–	–	﹤0.01%	783
2022 Q2	$21K	Hold	267,285	–	–	﹤0.01%	937
2022 Q1	$32K	Sell	267,285 -432,015	-62%	-$69K	﹤0.01%	1044
2021 Q4	$128K	Sell	699,300 -700	-0.1%	-$145	﹤0.01%	782
2021 Q3	$144K	Hold	700,000	–	–	﹤0.01%	702
2021 Q2	$189K	Hold	700,000	–	–	0.01%	621
2021 Q1	$119K	Buy	+700,000	New	+$163K	﹤0.01%	494

Other funds holding VHAQ.RT

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Periscope Capital's VHAQ.RT Position: Q1 2024 in Review

Periscope Capital sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 200,000 shares — an estimated $10.8K sold.

Periscope Capital first reported a position in VHAQ.RT in Q1 2021 and held it in 12 quarters. The position peaked at $189K in Q2 2021. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

Periscope Capital reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
Periscope Capital sold 200,000 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $10.8K.
Periscope Capital first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2021 and held it in 12 quarters.
Periscope Capital's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $189K in Q2 2021.
5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Periscope Capital's 13F filing for Q1 2024, filed 13 May 2024.